Abstract
Compounds with a conjugated oxo-ene-oxo system were tested for inhibition of blood platelet aggregation. All compounds with this structure in trans configuration were effective inhibitors of aggregation induced by thrombin and by arachidonic acid. While the oxo- trans-ene-oxo system is prerequisite for such activity, other structural features of the compounds may be varied without loss of activity. Inhibition is exemplified by 9,12-dioxo- trans-10- and 10,13-dioxo- trans-11-octadecenoic acids and their methyl esters, by 11,14-dioxo- trans-12-eicosenoic acid, by 4,7-dioxo- trans-5-decene and by trans-dibenzoylethylene. The half-inhibition concentrations are in the order of 2–6 μM, with complete inhibition at 8–20 μM. According to experiments with the inhibiting 9,12-dioxo- trans-10-octadecenoic acid, the normal xoygenation of exogenous arachidonic acid by platelets is not affected but the thrombin-induced internal release of this acid seems to be abolished by the inhibitor. The inhibition of aggregation in the presence of exogenous arachidonic acid and its products suggest that the inhibitor also interferes with other events leading to aggregation. By implication from other properties of the oxo- trans-ene-oxo system, reaction with SH groups may be a mechanism for inhibition.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
